The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: BMC Cancer 13 (2013) 286
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Münster
- (wer)
-
Universitäts- und Landesbibliothek Münster
- (wann)
-
2013
- Urheber
-
Kerl, Kornelius Tobias
Ries, David
Unland, Rebecca
Borchert, Christiane
Moreno, Natalia
Hasselblatt, Martin
Jürgens, Heribert
Kool, Marcel
Görlich, Dennis
Eveslage, Maria
Jung, Manfred
Meisterernst, Michael
Frühwald, Michael
- URN
-
urn:nbn:de:hbz:6-94309669593
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kerl, Kornelius Tobias
- Ries, David
- Unland, Rebecca
- Borchert, Christiane
- Moreno, Natalia
- Hasselblatt, Martin
- Jürgens, Heribert
- Kool, Marcel
- Görlich, Dennis
- Eveslage, Maria
- Jung, Manfred
- Meisterernst, Michael
- Frühwald, Michael
- Universitäts- und Landesbibliothek Münster
Entstanden
- 2013
Ähnliche Objekte (12)
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
SWI/SNF-Komplex-assoziierte Tumordispositions-Syndrome
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician
Revisiting the genotype‐phenotype correlation in children with medullary thyroid carcinoma : a report from the GPOH‐MET registry
Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
SWI/SNF-Komplex-assoziierte Tumordispositions-Syndrome
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician
Revisiting the genotype‐phenotype correlation in children with medullary thyroid carcinoma : a report from the GPOH‐MET registry
Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup
The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
BRD9 inhibition, alone or in combination with cytostatic compounds as a therapeutic approach in rhabdoid tumors
Bridging molecular advancements and clinical challenges in pediatric oncology
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
EP-1382: Feasibility of proton therapy with concomitant chemotherapy for atypical teratoid rhabdoid tumors
Limbic encephalitis with LGI1 antibodies in a 14-year-old boy
Molecular subgrouping of atypical teratoid/rhabdoid tumors: a reinvestigation and current consensus
Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor
SWI/SNF-Komplex-assoziierte Tumordispositions-Syndrome
Non-malignant features of cancer predisposition syndromes manifesting in childhood and adolescence: a guide for the general pediatrician
Revisiting the genotype‐phenotype correlation in children with medullary thyroid carcinoma : a report from the GPOH‐MET registry